Dr. Mathew Poppe, MD, is the Clinical Director at the Senator Orrin G. Hatch Proton Therapy Center at Huntsman Cancer Institute(HCI), and a professor in the Department of Radiation Oncology at the University of Utah.
Join the conversation with Dr. Poppe, led by Mevion’s SVP of Commercial Development, Lionel Bouchet, Ph.D., to discuss HCI’s experience in proton therapy clinical application, research, training, and more at NAPT 2022.
Негізгі бет Proton Therapy at Huntsman Cancer Institute: A Conversation with Dr. Matthew Poppe
Пікірлер